Wang Bai-lin, Chen Xiao-ping, Zhai Shu-ping
Hepatic Surgery Center, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua Gan Zang Bing Za Zhi. 2003 Oct;11(10):609-11.
To investigate the relationship between the expression of mrp and both the responses to chemotherapy and the level of alpha-fetoprotein (AFP).
S-P immunohistochemical staining and in situ PCR were adopted to detect MRP and mRNA mrp in 54 cancer tissues taken from untreated HCC patients whose tumor could not be removed during the operation, 24 para-cancer tissues, and 12 posthepatitis cirrhosis paraffin-embedded tissues. The relationship between the expression of mrp and their curative effect to chemotherapy in all the patients was analyzed, so was the relationship between the expression of mrp and the level of AFP in 38 patients whose AFP was positive after operation.
The positive rates of expressing MRP and mRNA mrp in the three kinds of tissues were 61.1%, 25.0%, 33.3% and 77.8%, 37.5%, 41.7%, respectively, with higher rates in HCC tissues than those in other tissues (chi2=9.842, P< 0.01; chi2=13.956, P<0.01). The rates of curative effect to chemotherapy in groups of negative and positive MRP and mRNA mrp expression were 61.9%, 30.3% and 75.0%, 33.3%, respectively, with significant difference between the negative and positive groups (chi2=5.242, P<0.05; chi2=6.627, P< 0.05). As the same as the percentage of curative effect to chemotherapy, the rates of AFP level decreased evidently were 62.5%, 27.3% and 87.5%, 30.0%, with remarkable difference between the two groups (chi2=4.710, P<0.05; chi2=8.566, P<0.05).
The multidrug resistance (MDR) of HCC is related to mrp expression, which initiates the intrinsic MDR. There is an important significance by detecting mrp expression in selecting chemotherapeutic method, and the expression of mrp can act as an indicator for chemotherapeutic sensitivity in HCC patients.
探讨多药耐药相关蛋白(mrp)的表达与化疗反应及甲胎蛋白(AFP)水平之间的关系。
采用S-P免疫组化染色和原位PCR技术,检测54例手术中无法切除肿瘤的未经治疗的肝癌患者癌组织、24例癌旁组织及12例肝炎后肝硬化石蜡包埋组织中的MRP和mrp mRNA。分析所有患者中mrp表达与化疗疗效的关系,以及38例术后AFP阳性患者中mrp表达与AFP水平的关系。
三种组织中MRP和mrp mRNA的阳性表达率分别为61.1%、25.0%、33.3%和77.8%、37.5%、41.7%,肝癌组织中的表达率高于其他组织(χ2=9.842,P<0.01;χ2=13.956,P<0.01)。MRP和mrp mRNA表达阴性组与阳性组的化疗有效率分别为61.9%、30.3%和75.0%、33.3%,阴性组与阳性组之间有显著差异(χ2=5.242,P<0.05;χ2=6.627,P<0.05)。与化疗有效率情况相同,AFP水平明显下降的比率分别为62.5%、27.3%和87.5%、30.0%,两组之间有显著差异(χ2=4.710,P<0.05;χ2=8.566,P<0.05)。
肝癌的多药耐药(MDR)与mrp表达有关,mrp表达引发了肝癌的固有MDR。检测mrp表达对选择化疗方法具有重要意义,mrp表达可作为肝癌患者化疗敏感性的指标。